Stemiotics Licenses Modified RNA for Cell Reprogramming

Stemiotics, Inc. announces licensing of breakthrough modified RNA technology from CELLSCRIPT, LLC for the production of human pluripotent stem cells. Stemiotics, Inc., a supplier of stem cell generation services, today announced it has licensed key intellectual property pertaining to the application of modified RNA from CELLSCRIPT, LLC of Madison, WI.

http://ift.tt/1AOpEZp